Skip to content
MHTF logo

Maternal Health Task Force

  • Facebook
  • Twitter
  • Vimeo
  • Flickr
  • Email
  • About
  • Topics
  • Resources
  • Buzz
    • People’s Choice Buzz
  • Blog
MHTF Blog ›

Identifying and Treating Gestational Diabetes Among Women Living with HIV in Ethiopia

Posted on February 27, 2018February 27, 2018

By: Mebrahtu Abraha Gebremikael, Elke Konings and Christie Roberts, Management Sciences for Health (MSH)

Gestational diabetes may be a neglected contributor to the continuing high rates of maternal and neonatal mortality in sub-Saharan Africa. Without proper care, gestational diabetes—high blood sugar that is detected during pregnancy (and can include previously undetected pre-pregnancy diabetes)—increases the risk of eclampsia, miscarriage, obstructed labor, hemorrhage and fetal death, yet pregnant women in developing countries are rarely screened for the condition. Gestational diabetes is also a leading risk factor for preterm birth and stillbirth and can lead to other newborn health complications, such as abnormal birth weight, congenital malformation, respiratory distress syndrome and hypoglycemia.

A recent study conducted in Ethiopia by Management Sciences for Health at one rural and two urban health centers in the Tigray Region of Ethiopia aimed to understand the prevalence of gestational diabetes in Ethiopia and its risk factors and assess the feasibility of integrating low-cost services for gestational diabetes into antenatal care. The study found that relatively simple and low-cost interventions could help manage gestational diabetes for many women—but there were different outcomes among women living with HIV and those without the condition.

According to the study, more than 11% of the 1,242 pregnant women tested positive for gestational diabetes—higher than expected, since previous prevalence estimates of gestational diabetes in Ethiopia were between 4% and 9%. Nearly a quarter of the women living with HIV were diagnosed with gestational diabetes, compared with 11% of HIV-negative women.

HIV treatment and gestational diabetes

Among the HIV-positive pregnant women, 29% of those who were on antiretroviral treatment (ART) tested positive for gestational diabetes. By comparison, 15% of HIV-positive pregnant women who had not started ART prior to their pregnancies were diagnosed with gestational diabetes. This finding is especially important since Ethiopia has adopted the Option B+ treatment, which places all HIV-positive pregnant women on lifelong treatment.

The study also revealed challenges and discrepancies related to treatment for gestational diabetes. Whereas 79% of pregnant women with gestational diabetes brought their blood glucose levels to normal through low-cost behavioral interventions—including dietary changes and increased physical activity—after two weeks, less than half of the women living with HIV did so. Half of the pregnant women on ART responded positively to behavioral changes, compared to about a third of HIV-positive women not yet on ART.

Future directions

The study results are eye-opening and warrant more attention. First, the prevalence of gestational diabetes among HIV-positive women and the treatment results should be assessed on a larger scale, including the influence of ART. The high prevalence of gestational diabetes among HIV-positive pregnant women highlights the importance of screening all HIV-positive pregnant women for gestational diabetes, especially in light of expanding ART coverage and Ethiopia’s adoption of Option B+ treatment. Furthermore, HIV-positive pregnant women with gestational diabetes may need specialized treatment services. Additional research should develop and test effective new treatment models, especially in low-resource and rural settings, where women frequently have trouble accessing regular care.

Since gestational diabetes is on the rise globally, understanding its prevalence and treatment options among all women—including those living with HIV—is fundamental to ending preventable maternal mortality.

—

Learn more about targeting gestational diabetes during antenatal care>>

Access key resources related to gestational diabetes>>

Browse published posts in the MHTF’s “Noncommunicable Diseases and Maternal Health” blog series.

Photo Credit: Warren Zelman

Share this:FacebookTwitterLinkedInReddit
CATEGORIESCATEGORIES: Contributor Posts Noncommunicable Diseases and Maternal Health
TOPICSTOPICS: Antenatal Care Barriers to Health Care Access Health Systems HIV & AIDS Inequities & Inequalities Infectious Disease Maternal Morbidity Maternal Mortality Monitoring & Evaluation Nutrition Social Determinants
GEOGRAPHIESGEOGRAPHIES: Ethiopia Sub-Saharan Africa

Looking for something specific?

Blog Series

  • Improving Maternal Health Measurement
  • Noncommunicable Diseases and Maternal Health
  • The Global Maternal Health Workforce
  • Quality of Maternal Health Care
  • See more>>

Archives

Blogs we follow

  • Healthy Newborn Network
  • Jacaranda Health
  • Jhpiego Field Notes
  • MamaYe
  • Maternal and Child Survival
  • NPR Goats and Soda
  • White Ribbon Alliance
  • Women Deliver

MHTF Disclaimer

The posts on this blog do not necessarily reflect the views of the Maternal Health Task Force. Our objective is to provide a platform for our Editorial Committee and other experts to post a myriad of data and evidence, as well as opinions/views that exist in the field which will contribute to expanding the maternal health dialogue.
  • About
  • Topics
  • Resources
  • Buzz
    • People’s Choice Buzz
  • Blog

MATERNAL HEALTH TASK FORCE

Harvard Chan School Center of Excellence in Maternal and Child Health
677 Huntington Avenue
Boston, MA 02115
MHTF@hsph.harvard.edu

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant T76MC00001 and entitled Training Grant in Maternal and Child Health. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.
  • About
    • Key Facts
    • Renaming the School
    • Office of the Dean
    • Location and Facilities
    • Administrative Offices
    • Contact Information
  • Admissions
    • Office of Admissions
    • Harvard Chan Viewbook
    • Financial Aid
    • Registrar’s Office
    • Summer at the School
  • Academics
    • Departments
    • Degrees
    • Online Degree Program
    • Programs and Requirements
    • Executive/Summer Programs
    • Interdisciplinary Concentrations
    • Office of Education
    • Division of Biological Sciences
    • Division of Policy Translation and Leadership Development
    • Executive and Continuing Professional Education
    • Fellowships and Residencies
    • Academic Calendar
    • Harvard Chan Viewbook
  • Exec Ed
  • Research
    • Office of Research Strategy and Development
    • Harvard Longwood Campus Research Administration
    • Office of Regulatory Affairs and Research Compliance
    • Office of Human Research Administration
    • Centers & Institutes
    • Researchers Directory
    • Postdoctoral Research Fellows
    • Export Controls
    • International Research
  • Faculty
    • Office of Faculty Affairs
    • Office of Diversity and Inclusion
    • Faculty Directory
    • Faculty Searches
  • Students
    • Student Life Main
    • Academic Calendar
    • Career Advancement
    • Countway Library
    • Housing
    • Student News
    • Office for Student Affairs
    • Office of Education
    • Office of Diversity and Inclusion
    • Office of Financial Aid
    • Registrar’s Office
    • Student Billing
    • Orientation
    • Commencement
  • Alumni
  • News
    • News Main
    • Press Releases
    • Harvard Public Health Magazine
    • Explore Research by Topic
    • Mailing Lists
    • Multimedia
    • Office of Communications
  • Make a Gift
    • Campaign for Harvard Chan School
  • Facebook
  • Twitter
  • Vimeo
  • Flickr
  • Email
Maternal Health Task Force Proudly powered by WordPress